Not applicableUnknownNCT04662138What this trial is testingSafety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus RelapseWho this might be right forHepatitis CRelapseAntivirals Alexandria University 100
Testing effectiveness (Phase 2)Study completedNCT02253550What this trial is testingSimeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus InfectionWho this might be right forChronic Hepatitis C Peter J. Ruane, M.D. 30
Early research (Phase 1)Study completedNCT01740791What this trial is testingStudy to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV InfectionWho this might be right forChronic Hepatitis C Virus Gilead Sciences 103
Large-scale testing (Phase 3)Ended earlyNCT00662220What this trial is testingHigh-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4Who this might be right forChronic Hepatitis C Foundation for Liver Research 110
Not applicableUnknownNCT01758939What this trial is testingPredictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian PatientsWho this might be right forHepatitis C, Chronic Cairo University 100,000
Post-approval studies (Phase 4)Study completedNCT03499639What this trial is testingOmbitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney DiseaseWho this might be right forEnd-stage Renal DiseaseHCV Coinfection Assiut University 110
Testing effectiveness (Phase 2)Study completedNCT04387539What this trial is testingٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced ParticipantsWho this might be right forChronic Hepatitis C Virus Infection Beni-Suef University 94
Testing effectiveness (Phase 2)Study completedNCT01685203What this trial is testingEvaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus InfectionWho this might be right forHepatitis C, Chronic AbbVie (prior sponsor, Abbott) 316
Testing effectiveness (Phase 2)Study completedNCT01439373What this trial is testingSafety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsWho this might be right forHepatitis C, Chronic GlaxoSmithKline 16
Not applicableUnknownNCT04934605What this trial is testingGenotype-phenotype Correlation of SLC26A4 in CI Patients With EVAWho this might be right forSensorineural Hearing LossEnlarged Vestibular Aqueduct Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Post-approval studies (Phase 4)Study completedNCT00356486What this trial is testingViral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIVWho this might be right forHIV Infections Germans Trias i Pujol Hospital 74
Testing effectiveness (Phase 2)Study completedNCT00759200What this trial is testingSafety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C PatientsWho this might be right forChronic Hepatitis C Novartis 525
Testing effectiveness (Phase 2)Study completedNCT02081079What this trial is testingEfficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 4 or 5 HCV InfectionWho this might be right forChronic Genotype 4 HCVChronic Genotype 5 HCV Gilead Sciences 85
Not applicableStudy completedNCT01054742What this trial is testingObservational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)Who this might be right forHepatitis C Merck Sharp & Dohme LLC 2
Post-approval studies (Phase 4)Ended earlyNCT03797066What this trial is testingATTIC - Access To Treat in the CommunityWho this might be right forHepatitis C, Chronic King's College Hospital NHS Trust 13
Testing effectiveness (Phase 2)Study completedNCT00704405What this trial is testingSafety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 285
Large-scale testing (Phase 3)Study completedNCT03186313What this trial is testingEvaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV InfectionWho this might be right forHepatitis C Egyptian Liver Hospital 72
Large-scale testing (Phase 3)Study completedNCT01448044What this trial is testingPhase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis CWho this might be right forHepatitis C Bristol-Myers Squibb 152
Testing effectiveness (Phase 2)Study completedNCT04391985What this trial is testingSofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 PatientsWho this might be right forChronic Hepatitis C Virus Infection Beni-Suef University 113
Testing effectiveness (Phase 2)Ended earlyNCT02956629What this trial is testingEfficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)Who this might be right forHepatitis C Merck Sharp & Dohme LLC 282